Monash Health builds clinical trial capabilities for alternative treatment to chemotherapy
Monash Health is providing renewed hope to cancer patients who do not respond well to chemotherapy. The Monash Health Haematology team has recently developed clinical trial capabilities for studies utilising a form of immunotherapy called CAR-T cells (chimeric antigen receptor T-cells).
Monash Health in the media: breakthrough in non-Hodgkin lymphoma treatment
A global clinical trial of a new treatment for people with an aggressive form of blood cancer has shown exciting results.
Cutting-edge genomic testing improving outcomes for people with cancer
The Monash Health Pathology team’s implementation of pan-cancer genomic testing has put it at the forefront of cancer care and presented staff with a valuable learning opportunity.
New tailored supports for adolescent and young adult cancer patients
Monash Health introduces new genetic testing for blood cancer patients
“New frontier” of cancer treatment receives early FDA approval
Inaugural Stem Cell Transplant in Cancer Patients a Success
Monash Health can now offer autologous stem cell transplantation (ASCT) to some cancer patients. This is a significant milestone for Monash Health as patients no longer need to travel to other healthcare services to receive this life-saving, potentially curative treatment.